ExpreS2ion Biotech Holding AB (EXPRS2.ST) revealed Loss for third quarter of -SEK8.445 million
The company's earnings came in at -SEK8.445 million, or -SEK2.33 per share. This compares with -SEK10.460 million, or -SEK2.83 per share, last year.
The company's revenue for the period rose 36.1% to SEK2.298 million from SEK1.689 million last year.
ExpreS2ion Biotech Holding AB earnings at a glance (GAAP) :
-Earnings: -SEK8.445 Mln. vs. -SEK10.460 Mln. last year.-EPS: -SEK2.33 vs. -SEK2.83 last year.-Revenue: SEK2.298 Mln vs. SEK1.689 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.